FDA Docket Submissions

Jordt, S. (November 22, 2013). Menthol in cigarettes, and tobacco products. Docket No. FDA-2013-N-0521.

Kong, G., and Krishnan-Sarin, S. (July 29, 2014). FDA should prohibit the sale of e-cigarettes to youth, and restrict flavors and visible vapors and advertisements to protect youth from e-cigarettes. Docket No: FDA-2014-N-0189-0001.

Bold, K. and Krishnan-Sarin, S. (March 4, 2016). Psychosocial predictors of uptake of tobacco and other products. Docket No: FDA-2016-N-0073.

Gutierrez, K. and Krishnan-Sarin, S. (March 4, 2016). E-cigarette initiation among youth: influence of advertising. Docket No: FDA-2016-N-0073.

Jordt, S., and Jabba, S. (October 8, 2018). High levels of the synthetic sweetener sucralose in R.J. Reynolds Snus Products may increase the risk of youth tobacco initiation and consumption of sucralose exceeding the FDA-recommended Acceptable Daily Intake (ADI). Docket No. FDA-2017-N-4678.

Jordt, S., and Jabba, S. (October 8, 2018). Modified Risk Tobacco Product Applications: Applications for Six Camel Snus Smokeless Tobacco Products Submitted by R.J. Reynolds Tobacco Company. Docket No. FDA-2017-N-4678.

Davis, D., and Kong, G. (October 4, 2019). Tobacco products; Required warnings for cigarette packages and advertisements. Docket No. FDA-2019-N-3065.

Jordt, S., and Jabba, S. (October 4, 2019). Harmful and potentially harmful constituents in tobacco products. Docket No. FDA-2012-N-0143.

Jordt, S., and Jabba, S. (October 4, 2019). Harmful and potentially harmful constituents in tobacco products - formation of flavorant–solvent adducts with novel toxicological properties Docket No. FDA-2012-N-0143.

Bagdas, D. (October 13, 2019). Tobacco products; Required warnings for cigarette packages and advertisements; Proposed rule docket. No. FDA-2019-N-3065.

Sen, I., and Kong, G. (October 15, 2019). FDA should introduce plain packaging of tobacco products with warning label in the USA. No. FDA-2019-N-3065.

Bold, K., and Camenga, D. (March 25, 2021). Enforcement Priorities for Electronic Nicotine Delivery Systems (ENDS) and Other Deemed Products on the Market Without Premarket Authorization, Guidance for Industry. Docket No. FDA-2019-D-0661-15418.

Morean, ME. (March 25, 2021). Recommendations for considering nicotine concentration labels on vaping product packaging as misleading and mandating exclusive use of mg/ml for labeling of vaping products Docket No. FDA-2019-D-0661.

Joseph, M., King, J., and Bold, K. (July 5, 2022). Tobacco Product Standard for Menthol in Cigarettes. Docket No. FDA-2021-N-1349-0001.

Jordt, S., and Jabba, S. (July 31, 2022). Tobacco Product Standard for Characterizing Flavors in Cigars. Docket No. FDA-2021-N-1309.

Jordt, S., and Jabba, S. (August 2, 2022). Tobacco Product Standard for Menthol in Cigarettes. Dockt No. FDA -2021-N-1349.

Kong, G., Lee, J., and Ouellette, R. (August 2, 2022). Prohibiting Characterizing Flavors in Cigars will Reduce Cigar and Marijuana Use and Health Disparities Among Youth. Docket No: FDA-2021-N-1309.

Morean, ME. (August 7, 2023). Nicotine concentration labels on ENDS product packaging should be considered by the FDA as misleading, and the FDA should mandate the exclusive use of mg/mL for labeling of ENDS products. Docket No. FDA-2013-N-0227.

Morean, ME, Ponte V, Li W. (September 28,2023). The FDA should enforce inclusion of its mandated nicotine addiction warning label (i.e., “This product contains nicotine. Nicotine is an addictive chemical.”) on product packaging without alteration and irrespective of nicotine source. Docket No. FDA-2013-N-0227_2.

Sharma, A., and Erythropel, HC. (October 6, 2023). Inconsistency between listing of e-liquid constituents and final product composition. Docket No. FDA-2013-N-0227.